520 related articles for article (PubMed ID: 24385079)
1. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.
Ho MC; Hsu WC; Hsieh YT
JAMA Ophthalmol; 2014 Mar; 132(3):332-7. PubMed ID: 24385079
[TBL] [Abstract][Full Text] [Related]
2. Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids.
Arat YO; Yen MT
Ophthalmic Plast Reconstr Surg; 2007; 23(1):22-4. PubMed ID: 17237684
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids.
Hui JI; Lee WW
Ophthalmic Plast Reconstr Surg; 2007; 23(6):433-8. PubMed ID: 18030112
[TBL] [Abstract][Full Text] [Related]
4. Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.
Choi MG; Yeo JH; Kang JW; Chun YS; Lee JK; Kim JC
Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):331-338. PubMed ID: 30552510
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland: a case report.
Riemann R; Pfennigsdorf S; Riemann E; Naumann M
Ophthalmology; 1999 Dec; 106(12):2322-4. PubMed ID: 10599665
[TBL] [Abstract][Full Text] [Related]
6. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm.
Park DI; Shin HM; Lee SY; Lew H
Acta Ophthalmol; 2013 Mar; 91(2):e108-12. PubMed ID: 23425111
[TBL] [Abstract][Full Text] [Related]
7. Effect of eyelid botulinum toxin injection on lacrimal drainage.
Sahlin S; Chen E; Kaugesaar T; Almqvist H; Kjellberg K; Lennerstrand G
Am J Ophthalmol; 2000 Apr; 129(4):481-6. PubMed ID: 10764857
[TBL] [Abstract][Full Text] [Related]
8. Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology.
Kaltreider SA; Kennedy RH; Woog JJ; Bradley EA; Custer PL; Meyer DR; ;
Ophthalmology; 2005 Jun; 112(6):1159-67. PubMed ID: 15936443
[TBL] [Abstract][Full Text] [Related]
9. Intraglandular injection of botulinum toxin a reduces tear production in rabbits.
Demetriades AM; Leyngold IM; D'Anna S; Eghrari AO; Emmert DG; Grant MP; Merbs SL
Ophthalmic Plast Reconstr Surg; 2013; 29(1):21-4. PubMed ID: 23128538
[TBL] [Abstract][Full Text] [Related]
10. Orbicularis oculi weakness and obstructive meibomian gland disease.
Allen RC; Wise RJ
JAMA Ophthalmol; 2014 Dec; 132(12):1490-1. PubMed ID: 25210995
[No Abstract] [Full Text] [Related]
11. Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection.
Kocabeyoglu S; Sekeroglu HT; Mocan MC; Muz E; Irkec M; Sanac AS
Eur J Ophthalmol; 2014; 24(6):830-4. PubMed ID: 24803156
[TBL] [Abstract][Full Text] [Related]
12. Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines.
Glogau R; Blitzer A; Brandt F; Kane M; Monheit GD; Waugh JM
J Drugs Dermatol; 2012 Jan; 11(1):38-45. PubMed ID: 22206075
[TBL] [Abstract][Full Text] [Related]
13. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
Gunes A; Demirci S; Koyuncuoglu HR; Tok L; Tok O
Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines.
Brandt F; O'Connell C; Cazzaniga A; Waugh JM
Dermatol Surg; 2010 Dec; 36 Suppl 4():2111-8. PubMed ID: 21134043
[TBL] [Abstract][Full Text] [Related]
15. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides.
Matarasso SL
Dermatol Surg; 2003 Jan; 29(1):7-13; discussion 13. PubMed ID: 12534505
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
Suwan-apichon O; Rizen M; Rangsin R; Herretes S; Reyes JM; Lekhanont K; Chuck RS
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):133-9. PubMed ID: 16384954
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye.
Horwath-Winter J; Bergloeff J; Floegel I; Haller-Schober EM; Schmut O
Br J Ophthalmol; 2003 Jan; 87(1):54-6. PubMed ID: 12488263
[TBL] [Abstract][Full Text] [Related]
18. Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study.
Pellegrini M; Schiavi C; Taroni L; Sebastiani S; Bernabei F; Roda M; Moscardelli F; Giannaccare G
Indian J Ophthalmol; 2019 Sep; 67(9):1405-1409. PubMed ID: 31436182
[TBL] [Abstract][Full Text] [Related]
19. Treatment of nasal wrinkles with botulinum toxin.
Tamura BM; Odo MY; Chang B; Cucé LC; Flynn TC
Dermatol Surg; 2005 Mar; 31(3):271-5. PubMed ID: 15841625
[TBL] [Abstract][Full Text] [Related]
20. Ocular surface changes following botulinum toxin injection for strabismus.
Taylan Sekeroglu H; Kocabeyoglu S; Mocan MC; Muz E; Karakaya J; Irkec M; Sanac AS
Cutan Ocul Toxicol; 2015; 34(3):185-8. PubMed ID: 25069002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
